414 results on '"Iansek, Robert"'
Search Results
2. Rehabilitation in movement disorders: From basic mechanisms to clinical strategies
3. Delivering Multidisciplinary Rehabilitation Care in Parkinson’s Disease: An International Consensus Statement
4. Expediting telehealth use in clinical research studies: recommendations for overcoming barriers in North America
5. Towards non-invasive peripheral stimulation as a treatment for Parkinson’s disease gait
6. Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results
7. Safety of Foslevodopa/Foscarbidopa During Optimization and Maintenance Treatment: Post Hoc Analysis of a Phase 3 Trial (S32.004)
8. The Use of Liquid Sinemet in Routine Clinical Practice of Advanced Parkinson’s Disease: A Comparison of Available Options
9. Parkinson’s disease
10. Reliability of measurements obtained with the timed 'Up and Go' test in people with Parkinson Disease
11. Additional file 1 of Health care experiences of people with Parkinson’s disease in Australia
12. Physical activity levels in people with Parkinson's disease treated by subthalamic nucleus deep brain stimulation.
13. Validation of the Rainbow Model of Integrated Care Measurement Tool in Parkinson's Disease.
14. Physical activity levels in people with Parkinson’s disease treated by subthalamic nucleus deep brain stimulation
15. Practical approaches to commencing device‐assisted therapies for Parkinson disease in Australia
16. Real-world Effect of Age on Long-term Effectiveness and Safety of Levodopa-Carbidopa Intestinal Gel: A Post Hoc Analysis From the Prospective, Multinational, Observational DUOGLOBE Study (P9-11.007)
17. Long-term Motor and Non-Motor Symptom Benefits in Patients With Advanced Parkinson’s Disease Treated With Levodopa-Carbidopa Intestinal Gel: Final Analysis of the 36-Month DUOGLOBE Real-world Multinational Observational Study (P1-1.Virtual)
18. Long-term Motor and Non-Motor Symptom Benefits in Patients With Advanced Parkinson’s Disease Treated With Levodopa-Carbidopa Intestinal Gel by Baseline Hoehn & Yahr Stage: Analysis of the DUOGLOBE Study (P1-1.Virtual)
19. Outcomes Impacting Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel
20. Electrophysiological Signs of Supplementary-Motor-Area Deficits in High-Functioning Autism but Not Asperger Syndrome: An Examination of Internally Cued Movement-Related Potentials
21. Determinants of health-related quality of life in people with Parkinson’s disease: a path analysis
22. Freezing of gait in Parkinson's disease: Further insights into pathophysiological mechanisms
23. 51 - Rehabilitation in Movement Disorders
24. Central gait control mechanisms and the stride length – cadence relationship
25. Management of the hospitalized patient with Parkinson’s disease: Current state of the field and need for guidelines
26. Freezing of Gait and Activity Limitations in People With Parkinson's Disease
27. Sustained improvements in motor and non-motor symptoms in advanced Parkinson's disease patients treated with carbidopa levodopa enteral suspension in a ‘real-world’ study
28. A long-term community gym program for people with Parkinson's disease: a feasibility study of the Monash Health "Health and Fitness" model.
29. Optimizing care of residents with Parkinsonism in supervised facilities
30. A long-term community gym program for people with Parkinson’s disease: a feasibility study of the Monash Health “Health and Fitness” model
31. DUOGLOBE : One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease
32. Sustained Improvements in Motor and Non-Motor Symptoms in Advanced Parkinson’s Disease Patients Treated with Carbidopa Levodopa Enteral Suspension in a ‘Real-World’ Study: Interim Results of the Multinational DUOGLOBE Study With at Least 24 Months Follow-Up (4584)
33. Differentiation of High-Functioning Autism and Asperger’s Disorder Based on Neuromotor Behaviour
34. Gait function in high-functioning autism and Asperger’s disorder: Evidence for basal-ganglia and cerebellar involvement?
35. Rehabilitation of Parkinson’s disease
36. Application of the ‘5-2-1’ screening criteria in advanced Parkinson’s disease: interim analysis of DUOGLOBE
37. Movement-related potentials in Huntington's disease: movement preparation and execution
38. Bimanual co-ordination in Huntington's disease
39. Oral formulations of L dopa and continuous dopaminergic stimulation
40. Examination of Central Gait Control Mechanisms in Parkinsonʼs Disease Using Movement–Related Potentials
41. Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson’s Disease
42. Integrated Care in Parkinson's Disease: A Systematic Review andMeta‐Analysis
43. Improvements in Dyskinesia with Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients in a ‘Real-World’ Study: Interim Results of the Multinational DUOGLOBE Study With up to 24 Months Follow-Up (1824)
44. Patients’ Perspective of Comprehensive Parkinson Care in Rural Victoria
45. Does old age or Parkinson's disease cause bradyphrenia?
46. Electrophysiological signs of supplementary-motor-area deficits in high-functioning autism but not Asperger syndrome: an examination of internally cued movement-related potentials
47. Gait freezing in Parkinsonʼs disease and the stride length sequence effect interaction
48. A randomized controlled trial of movement strategies compared with exercise for people with Parkinsonʼs disease
49. Head and trunk rotation during walking turns in Parkinsonʼs disease
50. Gait festination and freezing in Parkinsonʼs disease: Pathogenesis and rehabilitation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.